BlackRock’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1M Buy
10,810,481
+128,702
+1% +$144K ﹤0.01% 3258
2025
Q1
$8.44M Sell
10,681,779
-259,803
-2% -$205K ﹤0.01% 3363
2024
Q4
$18.1M Buy
10,941,582
+468,332
+4% +$773K ﹤0.01% 3069
2024
Q3
$36.7M Buy
10,473,250
+357,144
+4% +$1.25M ﹤0.01% 2625
2024
Q2
$33.2M Buy
10,116,106
+1,016,155
+11% +$3.33M ﹤0.01% 2642
2024
Q1
$66.8M Sell
9,099,951
-2,112,865
-19% -$15.5M ﹤0.01% 2250
2023
Q4
$41.9M Sell
11,212,816
-1,271,674
-10% -$4.76M ﹤0.01% 2548
2023
Q3
$26.5M Buy
12,484,490
+505,932
+4% +$1.07M ﹤0.01% 2734
2023
Q2
$57M Buy
11,978,558
+502,315
+4% +$2.39M ﹤0.01% 2358
2023
Q1
$65.4M Buy
11,476,243
+1,750,019
+18% +$9.98M ﹤0.01% 2248
2022
Q4
$98.1M Buy
9,726,224
+1,808,803
+23% +$18.3M ﹤0.01% 1999
2022
Q3
$177M Buy
7,917,421
+501,445
+7% +$11.2M 0.01% 1554
2022
Q2
$184M Buy
7,415,976
+310,305
+4% +$7.69M 0.01% 1579
2022
Q1
$275M Buy
7,105,671
+45,119
+0.6% +$1.75M 0.01% 1424
2021
Q4
$413M Buy
7,060,552
+365,006
+5% +$21.4M 0.01% 1176
2021
Q3
$397M Buy
6,695,546
+99,586
+2% +$5.9M 0.01% 1165
2021
Q2
$572M Sell
6,595,960
-567,527
-8% -$49.3M 0.02% 911
2021
Q1
$591M Buy
7,163,487
+491,946
+7% +$40.6M 0.02% 864
2020
Q4
$607M Buy
6,671,541
+104,907
+2% +$9.54M 0.02% 766
2020
Q3
$262M Buy
6,566,634
+466,488
+8% +$18.6M 0.01% 1164
2020
Q2
$209M Buy
6,100,146
+514,786
+9% +$17.7M 0.01% 1322
2020
Q1
$124M Sell
5,585,360
-207,327
-4% -$4.6M 0.01% 1495
2019
Q4
$113M Buy
5,792,687
+534,343
+10% +$10.5M ﹤0.01% 1884
2019
Q3
$81.7M Buy
5,258,344
+80,055
+2% +$1.24M ﹤0.01% 2006
2019
Q2
$105M Sell
5,178,289
-12,985
-0.3% -$264K ﹤0.01% 1867
2019
Q1
$91.2M Buy
5,191,274
+159,491
+3% +$2.8M ﹤0.01% 1913
2018
Q4
$64.6M Buy
5,031,783
+1,562,252
+45% +$20M ﹤0.01% 2074
2018
Q3
$56.5M Buy
3,469,531
+183,701
+6% +$2.99M ﹤0.01% 2297
2018
Q2
$37.3M Buy
3,285,830
+382,821
+13% +$4.34M ﹤0.01% 2499
2018
Q1
$28.3M Buy
2,903,009
+1,197,716
+70% +$11.7M ﹤0.01% 2564
2017
Q4
$10.4M Buy
1,705,293
+43,499
+3% +$266K ﹤0.01% 3093
2017
Q3
$6.58M Buy
1,661,794
+3,067
+0.2% +$12.1K ﹤0.01% 3326
2017
Q2
$5.38M Buy
1,658,727
+1,572,438
+1,822% +$5.1M ﹤0.01% 3409
2017
Q1
$392K Buy
+86,289
New +$392K ﹤0.01% 3984